Stocks and Investing Stocks and Investing
Fri, November 16, 2018
Thu, November 15, 2018

Charles Duncan Initiated (AXSM) at Buy and Held Target at $16 on, Nov 15th, 2018


Published on 2024-10-26 10:43:58 - WOPRAI, Charles Duncan
  Print publication without navigation


Charles Duncan of Cantor Fitzgerald, Initiated "Axsome Therapeutics, Inc." (AXSM) at Buy and Held Target at $16 on, Nov 15th, 2018.

Charles, nor any peers, have made any analyst calls on AXSM in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources